Plaquenil: Effective Management of Autoimmune Conditions
| Product dosage: 200mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $5.01 | $50.09 (0%) | 🛒 Add to cart |
| 20 | $4.01 | $100.18 $80.14 (20%) | 🛒 Add to cart |
| 30 | $3.67 | $150.27 $110.20 (27%) | 🛒 Add to cart |
| 60 | $3.51 | $300.53 $210.37 (30%) | 🛒 Add to cart |
| 90 | $3.34 | $450.80 $300.53 (33%) | 🛒 Add to cart |
| 120 | $2.92 | $601.06 $350.62 (42%) | 🛒 Add to cart |
| 180 | $2.78 | $901.60 $500.89 (44%) | 🛒 Add to cart |
| 270 | $2.60 | $1352.40 $701.24 (48%) | 🛒 Add to cart |
| 360 | $2.39
Best per pill | $1803.19 $861.53 (52%) | 🛒 Add to cart |
| Product dosage: 400mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $7.01 | $70.12 (0%) | 🛒 Add to cart |
| 20 | $6.01 | $140.25 $120.21 (14%) | 🛒 Add to cart |
| 30 | $5.68 | $210.37 $170.30 (19%) | 🛒 Add to cart |
| 60 | $5.34 | $420.75 $320.57 (24%) | 🛒 Add to cart |
| 90 | $5.01 | $631.12 $450.80 (29%) | 🛒 Add to cart |
| 120 | $4.59 | $841.49 $550.98 (35%) | 🛒 Add to cart |
| 180 | $4.45 | $1262.24 $801.42 (37%) | 🛒 Add to cart |
| 270 | $4.27 | $1893.35 $1152.04 (39%) | 🛒 Add to cart |
| 360 | $4.03
Best per pill | $2524.47 $1452.57 (42%) | 🛒 Add to cart |
Plaquenil, known generically as hydroxychloroquine sulfate, is a disease-modifying antirheumatic drug (DMARD) widely prescribed for its immunomodulatory and anti-inflammatory properties. It is a cornerstone in the long-term management of several chronic autoimmune disorders, offering patients a means to control disease activity, reduce symptom flare-ups, and protect against progressive tissue damage. Its well-established efficacy and generally favorable tolerability profile have made it a first-line therapeutic option in rheumatology and dermatology. This medication requires careful medical supervision to maximize benefits and minimize potential risks.
Features
- Active Ingredient: Hydroxychloroquine sulfate
- Available Strengths: 200 mg tablets
- Drug Class: Antimalarial/4-Aminoquinoline, Disease-Modifying Antirheumatic Drug (DMARD)
- Mechanism of Action: Modulates immune system activity, inhibits antigen presentation, and suppresses cytokine production
- Prescription Status: Requires a prescription from a licensed healthcare provider
- Manufacturing Standards: Produced under strict pharmaceutical quality controls
Benefits
- Provides sustained suppression of autoimmune activity, leading to reduced frequency and severity of disease flares
- Helps preserve joint function and mobility in rheumatic diseases by slowing disease progression
- Offers protective effects against irreversible organ damage, particularly in systemic lupus erythematosus
- Can reduce dependency on higher-dose corticosteroids, minimizing their associated adverse effects
- Demonstrates efficacy in managing cutaneous manifestations of autoimmune disorders
- Supports long-term disease remission and improved quality of life
Common use
Plaquenil is primarily indicated for the treatment of autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, and discoid lupus erythematosus. It is used both as monotherapy and in combination with other DMARDs or biologic agents to achieve comprehensive disease control. In rheumatology, it helps manage joint pain, swelling, and stiffness, while in lupus, it addresses systemic symptoms including fatigue, skin rashes, and joint involvement. Off-label uses may include certain dermatological conditions like porphyria cutanea tarda and Sjögren’s syndrome, always under specialist guidance.
Dosage and direction
Dosage is strictly individualized based on the patient’s weight, renal function, and specific condition. For adults, the typical initial dose is 400-600 mg daily, often divided, followed by a maintenance dose of 200-400 mg daily. Dosing should be calculated on ideal body weight to minimize retinal toxicity risk, not exceeding 5.0 mg/kg actual body weight. Administration with food or milk is recommended to reduce gastrointestinal upset. Regular ophthalmic examinations are mandatory due to the risk of retinopathy with prolonged use.
Precautions
Patients should undergo a baseline ophthalmologic examination within the first year of starting therapy and annually thereafter after five years of use. Renal and hepatic function should be monitored periodically. Use with caution in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency due to hemolysis risk. May exacerbate psoriasis. Caution advised in those with hepatic disease or alcoholism. Patients should be advised that therapeutic effects may not be apparent for several weeks to months.
Contraindications
Plaquenil is contraindicated in patients with known hypersensitivity to hydroxychloroquine or 4-aminoquinoline compounds. It should not be used in patients with pre-existing retinal field changes attributable to 4-aminoquinoline compounds. Contraindicated in patients with known porphyria. Not recommended for use in children except for juvenile idiopathic arthritis under specialist care.
Possible side effect
Common side effects include gastrointestinal symptoms (nausea, diarrhea, abdominal cramps), headache, and skin eruptions. More serious but rare adverse effects include irreversible retinopathy, cardiomyopathy, and neuromyotoxicity. Hematologic effects such as anemia, leukopenia, or thrombocytopenia may occur. Psychiatric effects including anxiety, depression, and rare psychosis have been reported. Pigmentary changes in skin and mucous membranes may develop with long-term use.
Drug interaction
Plaquenil may potentiate the effects of digoxin and insulin or oral hypoglycemics. Concurrent use with other QT-prolonging drugs increases arrhythmia risk. May reduce seizure threshold when used with antiepileptics. Absorption reduced by antacids and kaolin; administer at least 4 hours apart. May increase plasma levels of methotrexate when used concomitantly. Caution with hepatotoxic drugs due to additive effects.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose. Do not double the dose to make up for a missed one. Maintain regular dosing schedule to ensure consistent therapeutic levels. Consult healthcare provider if multiple doses are missed.
Overdose
Overdose can be fatal, with symptoms including headache, drowsiness, visual disturbances, cardiovascular collapse, and seizures. Cardiac monitoring is essential as QT prolongation and life-threatening arrhythmias may occur. Treatment is supportive with immediate gastric lavage if presented early. Activated charcoal may be administered. No specific antidote exists; management focuses on symptomatic care and cardiac monitoring.
Storage
Store at room temperature (15-30°C or 59-86°F) in a dry place, protected from light. Keep in original container with tight closure. Do not store in bathroom or damp areas. Keep out of reach of children and pets. Do not use after expiration date printed on packaging.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Plaquenil is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Individual response to therapy may vary. Always consult your physician for diagnosis and treatment recommendations tailored to your specific medical condition.
Reviews
Clinical studies and long-term observational data consistently demonstrate Plaquenil’s efficacy in maintaining disease remission and preventing disease progression in autoimmune conditions. Many patients report significant improvement in quality of life and functional capacity. The drug’s favorable benefit-risk profile when properly monitored makes it a valuable therapeutic option. However, patients should maintain regular follow-up appointments to monitor for potential adverse effects, particularly ocular toxicity.